Bank of New York Mellon’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,020
| Closed | -$3.08K | – | 4305 |
|
|
2024
Q1 | $3.08K | Hold |
22,020
| – | – | ﹤0.01% | 4135 |
|
|
2023
Q4 | $3.2K | Hold |
22,020
| – | – | ﹤0.01% | 4291 |
|
|
2023
Q3 | $3.86K | Hold |
22,020
| – | – | ﹤0.01% | 4323 |
|
|
2023
Q2 | $68.7K | Buy |
+22,020
| New | +$68.7K | ﹤0.01% | 4119 |
|
|
2021
Q2 | – | Sell |
-32,303
| Closed | -$285K | – | 4483 |
|
|
2021
Q1 | $285K | Sell |
32,303
-1,970
| -6% | -$17.4K | ﹤0.01% | 3925 |
|
|
2020
Q4 | $351K | Buy |
34,273
+10,142
| +42% | +$104K | ﹤0.01% | 3764 |
|
|
2020
Q3 | $218K | Hold |
24,131
| – | – | ﹤0.01% | 3817 |
|
|
2020
Q2 | $172K | Buy |
24,131
+12,535
| +108% | +$89.3K | ﹤0.01% | 3833 |
|
|
2020
Q1 | $111K | Buy |
+11,596
| New | +$111K | ﹤0.01% | 3840 |
|